Hepatitis C virus recurrence after liver transplantation

Gut

Volumn 44, Issue 4, 1999, Pages 575-578

  Bizollon, T ^a   Ducerf, C ^a   Trepo, C ^a   Mutimer, D ^b  

^a HÔTEL DIEU   (France)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; RIBAVIRIN;

HEPATITIS C; HUMAN; IMMUNOTHERAPY; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; VIRUS REACTIVATION;

EID: 0032902122     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.44.4.575     Document Type: Review

References (57)

1. Kuo G, Choo QL, Alter HJ, et al. An assay for circulating antibodies to a major etiologic virus of human non-A non-B hepatitis. Science 1989;244:362-4.
2. Di Bisceglie AM, Goodmann ZD, Ishak KG, et al. Long term clinical and histopathological follow up of chronic post-transfusion hepatitis. Hepatology 1991;14:969-74.
3. Di Bisciglie AM. Hepatitis C and hepatocellular carcinoma. Semin Liver Dis 1995;15:64-9.
4. Tine F, Magin S, Craxi A, et al. Interferon for non-A, non-B chronic hepatitis, a meta-analysis of randomised clinical trials. J Hepatol 1991;13:192-9.
5. Ascher NL, Lake JR, Emond J, et al. Liver transplantation for hepatitis C virus-related cirrhosis. Consensus conference on indications of liver transplantation. Hepatology 1994;20:24-7S.
6. European Liver Transplant Registry (June 1994). Centre Hépato-Biliaire, Hopital Paul Brousse, Villejuif, France, 1994.
7. Weiner AJ, Brauer MJ, Rosenblatt J, et al. Variable and hypervariable domains are found in the region of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. Virology 1991;180:842-8.
8. Saleh MG, Tibbs CJ, Pereira LMMB, et al. HCV-RNA in peripheral blood mononuclear cells but not in liver: evidence for extra-hepatic HCV replication in the absence of extra-hepatic replication [abstract]. Hepatology 1993;18:81A.
9. El-Ashmany L, Hassanein T, Gavaler JS, et al. Prevalence of hepatitis C virus antibody in a liver tranplantation population. Dig Dis Sci 1992;37:1110-15.
10. Knoop M, Bechstein WO, Blumhardt G, et al. Recurrent hepatitis C infection after orthotopic liver transplantation. Transplant Proc 1995;27:1208-10.
11. Read AE, Donegan E, Lake J, et al. Hepatitis C in patients undergoing liver transplantation. Ann Intern Med 1991;114:282-4.
12. Potuchera JJ, Rakela J, Lumeng L, et al. Diagnosis of chronic hepatitis C after transplantation by the detection of viral sequences with polymerase chain reaction. Hepatology 1992;15:42-5.
13. Feray C, Samuel D, Thiers V, et al. Reinfection of liver graft by hepatitis C virus after liver transplantation. J Clin Invest 1992;89:1361-5.
14. Zhou S, Terrault NA, Ferrell L, et al. Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremia. Hepatology 1996;24:1041-6.
15. Wright TL, Donegan E, Hsu HH, et al. Recurrent and acquired hepatitic viral infection in liver transplant recipients. Gastroenterology 1992;103:317-22.
16. Weinstein JS, Poterucha JJ, Zein N, et al. Epidemiology and natural history of hepatitis C infections in liver transplant recipients. J Hepatol 1995;22(suppl 1):154-9.
17. König V, Bauditz J, Lobeck H, et al. Hepatitis C virus reinfection in allografts after orthotopic liver transplantation. Hepatology 1992;16:1137-43.
18. Gane EJ, Naoumov NV, Qian K-P, et al. A longitudinal analysis of hepatitis C virus replication following liver transplantation. Gastroenterology 1996;110:167-77.
19. Negro F, Giostra E, Rubbia-Brandt L, et al. IgM anti-hepatitis core antibody as marker of recurrent hepatitis C after liver transplantation [abstract]. Hepatology 1997;26:213A.
20. Chazouilleres O, Kim M, Combs C, et al. Quantitation of hepatitis C virus RNA in liver transplant recipients. Gastroenterology 1994;106:994-9.
21. Ferrell L, Wright TL, Roberts J, et al. Hepatitis C viral infection in liver transplant recipients. Hepatology 1992;16:865-76.
22. Loinaz C, Lumbreras C, Gonzalez-Pinto I, et al. high incidence of post-transplant hepatitis and chronic rejection associated with hepatitis C virus infection in liver transplant recipients. Transplant Proc 1995;27:1217-18.
23. Feray C, Gigou M, Samuel D, et al. The course of hepatitis C virus infection after liver transplantation. Hepatology 1994;20:1137-43.
24. Martin P, Munoz SJ, Di Bisceglie AM, et al. Recurrence of hepatitis C virus infection after orthotopic liver transplantation. Hepatology 1991;13:719-21.
25. Shuhart MC, Bronner MP, Gretch DR, et al. Histological and clinical outcome after liver transplantation for hepatitis C. Hepatology 1997;26:1646-52.
26. Casavilla A, Mateo R, Rakela J, et al. Impact of hepatitis C virus infection on survival following primary liver transplantation under FK506 [abstract]. Hepatology 1994;20:133A.
27. Gane EJ, Portmann BC, Naoumov NV, et al. Long term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996;334:815-20.
28. Boker KHW, Dalley G, Bahr MJ, et al. Long-term outcome of hepatitis C virus infection after liver transplantation. Hepatology 1997;25:203-10.
29. Singh N, Gayowsky T, Wagener MM, et al. Increased infections in liver transplant recipients with recurrent hepatitis C virus hepatitis. Transplantation 1996;61:402-6.
30. Lim HL, Lau GKK, Davis GL, et al. Cholestatic hepatitis leading to hepatic failure in a patient with organ-transmitted hepatitis C virus infection. Gastroenterology 1994;106:248-51.
31. Schluger LK, Sheiner PA, Thung SN, et al. Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation. Hepatology 1996;23:971-6.
32. Feray C, Gigou M, Samuel D, et al. Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation. Gastroenterology 1995;108:1088-96.
33. Sheiner PA, Sschluger LK, Emre S, et al. Retransplantation for recurrent hepatitis C. Liver Tranplant Surg 1997;3:130-6.
34. Martell M, Esteban JI, Quer J, et al. Dynamic behavior of hepatitis C virus quasispecies in patients undergoing orthotopic liver transplantation. J Virol 1994;68:3425-36.
35. Gonzales-Peralta RP, Naoumov NV, Liu WZ, et al. Evolution of hepatitis C virus quasispecies heterogeneity after liver transplantation [abstract]. Hepatology 1996;23(suppl):670A.
36. Berenguer M, Terrault NA, Piatak M, et al. Hepatitis G virus infection in patients with hepatitis C virus infection undergoing liver transplantation. Gastroenterology 1996;111:1569-75.
37. Colter SJ, Gretch DR, Bronner MP, et al. Hepatitis G virus coinfection does not alter the course of recurrent hepatitis C virus infection in liver transplant recipients. Hepatology 1997;26:432-6.
38. Bizollon T, Guichard S, Si Ahmed SN, et al. Impact of hepatitis G virus co-infection on the course of hepatitis C virus infection before and after liver transplantation. J Hepatol 1998;29:893-900.
39. Sheiner PA, Schwartz ME, Mor E, et al. Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation. Hepatology 1995;21:30-4.
40. The US Multicenter FK506 liver study group. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression in liver transplantation. N Engl J Med 1994;331:1110-15.
41. Rosen HR, Martin P, Shackleton CR, et al. OKT3 use associated with diminshed graft and patient survival in patients transplanted for chronic hepatitis C [abstract]. Hepatology 1996;22:132A.
42. Ascher NL. The role of the host immune state in recurrent hepatitis C. Liver Transplant Surg 1997;3:179-80.
43. Gretch D, Wile M, Gaur L, et al. Donor-recipient match at the HLA-DQB locus is associated with recrudescence of chronic hepatitis following liver transplantation for end-stage hepatitis C [abstract]. Hepatology 1993;18(suppl):18A
44. Calmus Y, Hannoun L, Dousset B, et al. HLA class I matching is responsible for the hepatic lesions in recurrent viral hepatitis B after liver transplantation. Transplant Proc 1990;22:2311-13
45. Rosen HR, Chou S, Corless CL, et al. Cytomegalovirus viremia. Risk factor for allograft cirrhosis after liver transplantation for hepatitis C. Transplantation 1997;64:721-6.
46. Larrea E, Garcia N, Quian C, et al. Tumor necrosis factor-alpha gene expression and the response to inteferon in chronic hepatitis C. Hepatology 1996;23:210.
47. Wright HI, Gavaler JS, Van Thiel DH. Preliminary experience with alpha-2b-interferon therapy of viral hepatitis in liver allograft recipients. Transplantation 1992;53:121-4.
48. Wright TL, Combs C, Kim M, et al. Interferon alpha therapy for hepatitis C virus infection after liver transplantation. Hepatology 1994;20:773-9.
49. Feray C, Samuel D, Gigou M, et al. An open trial of IFN alpha recombinant for hepatitis C after liver transplantation: antiviral effects and risk of rejection. Hepatology 1995;22:1084-9.
50. Cattral MS, Krajden M, Wanless IR, et al. A pilot study of ribavirin therapy for recurrent hepatitis C virus infection after liver transplantation. Transplantation 1996;61:1483-8.
51. Gane EJ, Tibbs CJ, Ramage JK, et al. Ribavirin therapy for hepatitis C infection following liver transplantation. Transplant Int 1995;8:61-4.
52. Bizollon T, Palazzo U, Ducerf C, et al. Pilot study of the combination of alpha interferon and ribavirin as therapy of recurrent hepatitis C after liver transplantation. Hepatology 1997;26:500-4.
53. Heagy W, Crumpacker C, Lopez PA, et al. Inhibition of immune functions by antiviral drugs. J Clin Invest 1991;87:1916-24.
54. Jolley W, Sharma B, Chami R, et al. Long-term skin allograft survival by combined therapy with suboptimal dose of cyclosporin and ribavirin. Transplant Proc 1988;20:703-6.
55. Van Thiel DH, Faruki H, Fagioli H, et al. Successful treatment of end-stage liver disease due to hepatitis C prior to liver transplantation [abstract]. Hepatology 1994;20:137A
56. Krawczynski K, Alter MJ, Tankersley DL, et al. Studies on protective efficacy of hepatitis C immunoglobulins in experimental hepatitis C infection [abstract]. Hepatology 1993;17:110A.
57. Feray C, Samuel D, Gigou M, et al. Reduced incidence of recurrent and acuqired infection by HCV after liver transplantation in patients receiving immunoglobulins [abstract]. Hepatology 1994;20:131A.